COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,973 Articles (22,604 medRxiv, 8,369 bioRxiv)

Most recent first Previous |  Page 582: Articles 5811-5820  | Next

Community engagement through student-led science for dengue prevention during the COVID-19 pandemic in Cordoba, Argentina.
Estallo, E. L., Madelon, M., Benitez, E., Stewart-Ibarra, A. M., Luduena-Almeida, F. F.
10.1101/2022.10.04.510837 — Posted: 2022-10-07
Upregulation of CD55 complement regulator in distinct PBMC subpopulations of COVID-19 patients is associated with suppression of interferon responses.
Detsika, M. G., Sakkou, M., Triantafyllidou, V., Konstantopoulos, D., Grigoriou, E., Psarra, K., Jahaj, E., Dimpoulou, I., Orfanos, S. E., Tsirogianni, A., Kollias, G., Kotanidou, A.
10.1101/2022.10.07.510750 — Posted: 2022-10-07
Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.
Mihalic, F., Benz, C., Kassa, E., Lindqvist, R., Simonetti, L., Inturi, R., Aronsson, H., Andersson, E., Chi, C. N., Davey, N. E., Overby, A. K., Jemth, P., Ivarsson, Y.
10.1101/2022.10.07.511324 — Posted: 2022-10-07
Fate and plasticity of SARS-CoV-2-specific B cells during memory and recall response in humans
Zurbuchen, Y., Michler, J., Taeschler, P., Adamo, S., Cervia, C., Raeber, M. E., Acar, I. E., Nilsson, J., Soyka, M. B., Moor, A. E., Boyman, O.
10.1101/2022.10.07.511336 — Posted: 2022-10-07
Baculoviral COVID-19 Delta DNA vaccine cross-protects against SARS-CoV2 variants in K18-ACE2 transgenic mice
Jang, Y., Cho, H., Chun, J., Park, K., Nowakowska, A., Kim, J., Lee, H., Lee, C., Han, Y., Lee, H.-J., Shin, H.-Y., Kim, Y. B.
10.1101/2022.10.07.511252 — Posted: 2022-10-07
Development of SARS-CoV-2 mRNA vaccines encoding spike N-terminal and receptor binding domains
Stewart-Jones, G., Elbashir, S. M., Wu, K., Lee, D., Renzi, I., Ying, B., Koch, M., Sein, C. E., Choi, A., Whitener, B., Garcia-Dominguez, D., Henry, C., Woods, A., Ma, L., Montes Berrueta, D., Avena, L. E., Quinones, J., Falcone, S., Hsiao, C. J., Scheaffer, S. M., Thackray, L. B., White, P., Diamond, M. S., Edwards, D. K., Carfi, A.
10.1101/2022.10.07.511319 — Posted: 2022-10-07
Neutralization of SARS-CoV-2 Omicron BA.4/BA.5 subvariant by a booster dose of bivalent adjuvanted subunit vaccine containing Omicron BA.4/BA.5 and BA.1 subvariants
Kuo, T.-Y., Lien, C. E., Lin, Y.-J., Lin, M.-Y., Liu, L. T.-C., Wu, C.-C., Tang, W.-H., Chen, C.
10.1101/2022.10.07.511263 — Posted: 2022-10-07
Incipient parallel evolution of SARS-CoV-2 Deltacron variant in South Brazil
Sant Anna, F. H., Andreis, T. F., Salvato, R. S., Muterle, A. P., Comerlato, J., Gregianini, T. S., Barcellos, R. B., Godinho, F. M., Resende, P. C., Wallau, G. L., Castro, T. R., Casarin, B. C., Vieira, A. A., Schwarzbold, A. V., Trindade, P. A., Giannini, G. L., Freese, L., Bristot, G., Brasil, C. S., Rocha, B. O., Martins, P. B., Oliveira, F. H., Oosterhout, C. v., Wendland, E.
10.1101/2022.10.06.511203 — Posted: 2022-10-07
Long COVID Risk and Pre-COVID Vaccination: An EHR-Based Cohort Study from the RECOVER Program
Brannock, M. D., Chew, R. F., Preiss, A. J., Hadley, E. C., McMurry, J. A., Leese, P. J., Girvin, A. T., Crosskey, M., Zhou, A. G., Moffitt, R. A., Jonsson Funk, M., Pfaff, E., Haendel, M., Chute, C. G., N3C Consortium, , RECOVER Consortium
10.1101/2022.10.06.22280795 — Posted: 2022-10-07
Impact of vaccination on post-acute sequelae of SARS CoV-2 infection in patients with rheumatic diseases
Patel, N. J., Cook, C., Vanni, K. M., Fu, X., Wang, X., Kawano, Y., Qian, G., Hang, B., Srivatsan, S., Banasiak, E., Kowalski, E., Bade, K., Zhang, Y., Sparks, J. A., Wallace, Z. S.
10.1101/2022.10.06.22280798 — Posted: 2022-10-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).